The Magazine for Sleep Professionals
Sunday, July 5, 2026
Masimo announced the results of a prospective study published in the International Journal of Neonatal Screening in which researchers in Marrakesh, Morocco, conducted the first Moroccan study on critical congenital heart disease (CCHD) screening for newborns using Masimo SET® pulse oximetry.1 The authors concluded that “Our results encourage us to strengthen screening for […]
Masimo announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the accuracy of Masimo RRp® on pediatric patients with the Rad-G™ Pulse Oximeter by comparing it to clinician-determined values while performing routine assessment of children admitted to outpatient and emergency departments.1 RRp provides respiration rate […]
Facial features analyzed from 3D photographs could predict the likelihood of having obstructive sleep apnea, according to a study published in the April issue of the Journal of Clinical Sleep Medicine. Using 3D photography, the study found that geodesic measurements — the shortest distance between two points on a curved surface — predicted […]
Introduction Sleep apnea, with an estimated incidence between three and seven percent in the general population, is a common disorder.1 Currently, either an at-home sleep test or overnight polysomnographic test is necessary to diagnose sleep apnea. Both of these evaluations are at times cumbersome. Consequently, patients may be unwilling to […]
Masimo announced that RD SET® sensors with Masimo Measure-through Motion and Low Perfusion™ SET® pulse oximetry have received FDA clearance for improved oxygen saturation (SpO2) accuracy specifications for neonatal patients (< 3 kg). The updated RD SET® sensors’ SpO2 accuracy specifications have improved significantly, from 3% to 1.5% ARMS1 (at 1 standard deviation), in conditions […]
By Sara Zaib Khan, MD, Sameer Verma, MD, Rammohan Gumpeni, MD, Arunabh Talwar, MD, F.C.C.P In recent years, the role of wearable technology has been expanding in healthcare. Wearable technology are devices that a consumer can wear on their clothing or on the body without interfering with daily activities.1 In […]
Masimo announced today FDA 510(k) clearance of Radius PPG, a tetherless sensor solution powered by Masimo SET® that represents a significant breakthrough in patient monitoring. Radius PPG eliminates the need for a cabled connection to a pulse oximetry monitor, allowing patients to move freely and comfortably while still being continuously monitored reliably […]
Masimo announced FDA clearance of the Rad-67™ Pulse CO-Oximeter® with Spot-check Next Generation SpHb® monitoring technology and the rainbow® DCI®-mini Reusable Sensor. Rad-67 offers rainbow® noninvasive hemoglobin measurement (SpHb) and Measure-through Motion and Low Perfusion™ SET® pulse oximetry in a compact, portable spot-check monitoring device. When used with the rainbow® DCI-mini sensor, Rad-67 provides spot-check monitoring […]
Masimo recently announced FDA clearance of the measurement of respiration rate from the pleth (RRp®) on the MightySat™ Rx spot-check fingertip pulse oximeter, as well as its indication for use in the home environment. The addition of RRp to MightySat Rx, which also measures functional oxygen saturation (SpO2), pulse rate (PR), […]
Masimo has announced the findings of a recently published study in which researchers investigated whether home pulse oximetry monitoring might be a useful initial screening method of determining which children with Down syndrome (DS) – who are at high risk of obstructive sleep apnea (OSA) – be recommended to undergo […]
